A high-density screen for linkage in multiple sclerosis.

PubWeight™: 2.50‹?› | Rank: Top 2%

🔗 View Article (PMC 1226210)

Published in Am J Hum Genet on July 29, 2005

Authors

Stephen Sawcer1, Maria Ban, Mel Maranian, Tai Wai Yeo, Alastair Compston, Andrew Kirby, Mark J Daly, Philip L De Jager, Emily Walsh, Eric S Lander, John D Rioux, David A Hafler, Adrian Ivinson, Jacqueline Rimmler, Simon G Gregory, Silke Schmidt, Margaret A Pericak-Vance, Eva Akesson, Jan Hillert, Pameli Datta, Annette Oturai, Lars P Ryder, Hanne F Harbo, Anne Spurkland, Kjell-Morten Myhr, Mikko Laaksonen, David Booth, Robert Heard, Graeme Stewart, Robin Lincoln, Lisa F Barcellos, Stephen L Hauser, Jorge R Oksenberg, Shannon J Kenealy, Jonathan L Haines, International Multiple Sclerosis Genetics Consortium

Author Affiliations

1: University of Cambridge, Department of Clinical Neuroscience, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, United Kingdom. sjs1016@mole.bio.cam.ac.uk

Articles citing this

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol (2010) 2.94

Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. Am J Hum Genet (2010) 2.64

Multiple sclerosis. J Clin Invest (2012) 2.41

HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. PLoS One (2007) 2.05

A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol (2007) 1.99

Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor. Eur J Hum Genet (2009) 1.97

The complex genetics of multiple sclerosis: pitfalls and prospects. Brain (2008) 1.68

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59

Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans. Genes Immun (2006) 1.56

Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures. Brain (2008) 1.37

Interrogating the major histocompatibility complex with high-throughput genomics. Hum Mol Genet (2012) 1.35

Performance of amplified DNA in an Illumina GoldenGate BeadArray assay. Cancer Epidemiol Biomarkers Prev (2008) 1.32

Large scale single nucleotide polymorphism discovery in unsequenced genomes using second generation high throughput sequencing technology: applied to turkey. BMC Genomics (2009) 1.31

Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin Exp Immunol (2008) 1.17

Multiple sclerosis genetics--is the glass half full, or half empty? Nat Rev Neurol (2010) 1.15

Pathophysiology of multiple sclerosis. J Neurol (2008) 1.15

Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission. BMC Med Genet (2008) 1.11

Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA. Arch Neurol (2009) 1.10

Genetics and pathogenesis of multiple sclerosis. Semin Immunol (2009) 1.06

Role of the MHC2TA gene in autoimmune diseases. Ann Rheum Dis (2006) 1.06

What role for genetics in the prediction of multiple sclerosis? Ann Neurol (2010) 1.05

Mining for single nucleotide polymorphisms in pig genome sequence data. BMC Genomics (2009) 1.02

CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis. Hum Mol Genet (2010) 1.01

Finding disease candidate genes by liquid association. Genome Biol (2007) 1.01

The immunogenetic architecture of autoimmune disease. Cold Spring Harb Perspect Biol (2012) 1.00

Association between protective and deleterious HLA alleles with multiple sclerosis in Central East Sardinia. PLoS One (2009) 1.00

Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility. Hum Genet (2010) 0.99

A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS One (2010) 0.98

Whole-genome amplification enables accurate genotyping for microarray-based high-density single nucleotide polymorphism array. Cancer Epidemiol Biomarkers Prev (2008) 0.98

Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics (2006) 0.97

Association between the ACCN1 gene and multiple sclerosis in Central East Sardinia. PLoS One (2007) 0.97

PRKCA and multiple sclerosis: association in two independent populations. PLoS Genet (2006) 0.95

Bayes factors in complex genetics. Eur J Hum Genet (2010) 0.93

Revealing the genetic basis of multiple sclerosis: are we there yet? Curr Opin Genet Dev (2011) 0.93

Meta-analysis of genome-wide linkage studies across autoimmune diseases. Eur J Hum Genet (2008) 0.92

Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet (2015) 0.90

No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis. Ann Neurol (2013) 0.87

Fine-mapping chromosome 20 in 230 systemic lupus erythematosus sib pair and multiplex families: evidence for genetic epistasis with chromosome 16q12. Am J Hum Genet (2006) 0.87

Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency. J Neuroimmunol (2007) 0.87

CCL genes in multiple sclerosis and systemic lupus erythematosus. J Neuroimmunol (2008) 0.86

The impact of the human genome project on complex disease. Genes (Basel) (2014) 0.85

A genome-wide linkage screen in the Amish with Parkinson disease points to chromosome 6. Ann Hum Genet (2011) 0.83

A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches. Hum Genet (2015) 0.82

TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes. Eur J Immunol (2011) 0.82

Environmental factors in early childhood are associated with multiple sclerosis: a case-control study. BMC Neurol (2011) 0.82

Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis. Genes Immun (2008) 0.82

Fine mapping and functional analysis of the multiple sclerosis risk gene CD6. PLoS One (2013) 0.81

Progress in multiple sclerosis genetics. Curr Genomics (2012) 0.81

Three allele combinations associated with multiple sclerosis. BMC Med Genet (2006) 0.80

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol (2009) 0.80

An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med Genet (2006) 0.78

Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study. Lung (2008) 0.77

Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort. Eur J Hum Genet (2014) 0.77

Genetic determinants of risk and progression in multiple sclerosis. Clin Chim Acta (2015) 0.77

Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. Genes Immun (2009) 0.76

NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk. Neuron (2016) 0.76

The genetic aspects of multiple sclerosis. Ann Indian Acad Neurol (2009) 0.75

Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders. Eur J Hum Genet (2011) 0.75

Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis. Int J Mol Sci (2016) 0.75

Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. Br J Pharmacol (2017) 0.75

Profile of differential promoter activity by nucleotide substitution at GWAS signals for multiple sclerosis. Medicine (Baltimore) (2014) 0.75

HLA class I & II alleles in multiple sclerosis patients from Puerto Rico. Bol Asoc Med P R (2013) 0.75

An integrated approach to design novel therapeutic interventions for demyelinating disorders. Eur J Neurosci (2012) 0.75

Early B-cell Factor gene association with multiple sclerosis in the Spanish population. BMC Neurol (2005) 0.75

The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years. Trends Genet (2017) 0.75

Burden of genetic risk variants in multiple sclerosis families in the Netherlands. Mult Scler J Exp Transl Clin (2016) 0.75

Articles cited by this

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

The future of genetic studies of complex human diseases. Science (1996) 64.76

Merlin--rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet (2001) 53.16

Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet (1995) 49.77

Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet (1996) 39.80

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

A high-resolution recombination map of the human genome. Nat Genet (2002) 28.66

New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67

Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36

PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet (1998) 23.25

Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet (1990) 19.91

A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet (2005) 18.98

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet (2005) 14.30

Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet (1997) 13.93

Comprehensive human genome amplification using multiple displacement amplification. Proc Natl Acad Sci U S A (2002) 13.58

Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet (1995) 12.78

A class of tests for linkage using affected pedigree members. Biometrics (1994) 10.40

Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol (2003) 8.65

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33

GRR: graphical representation of relationship errors. Bioinformatics (2001) 6.09

An Icelandic example of the impact of population structure on association studies. Nat Genet (2004) 5.53

Evaluating pedigree data. I. The estimation of pedigree error in the presence of marker mistyping. Am J Hum Genet (1983) 3.82

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature (1995) 3.57

Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet (2004) 3.47

Multiple sclerosis among immigrants in Greater London. Br Med J (1976) 3.24

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet (1996) 3.00

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet (1996) 2.98

A full genome search in multiple sclerosis. Nat Genet (1996) 2.96

Ordered subset analysis in genetic linkage mapping of complex traits. Genet Epidemiol (2004) 2.92

Timing of birth and risk of multiple sclerosis: population based study. BMJ (2004) 2.56

Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A (2003) 2.50

Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler (1999) 2.35

The impact of genotyping error on family-based analysis of quantitative traits. Eur J Hum Genet (2001) 2.12

HL-A antigens and multiple sclerosis. Lancet (1972) 2.09

Affected-sib-pair interval mapping and exclusion for complex genetic traits: sampling considerations. Genet Epidemiol (1996) 2.06

Linkage disequilibrium inflates type I error rates in multipoint linkage analysis when parental genotypes are missing. Hum Hered (2005) 1.86

Molecular and statistical approaches to the detection and correction of errors in genotype databases. Am J Hum Genet (1993) 1.84

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens (1991) 1.80

B-lymphocyte alloantigens associated with multiple sclerosis. Lancet (1976) 1.73

B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67

Multiple sclerosis: updated risks for relatives. Am J Med Genet (1988) 1.67

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet (1998) 1.63

Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet (2001) 1.60

Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet (1997) 1.57

The British Isles survey of multiple sclerosis in twins. Neurology (1994) 1.57

Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens (2004) 1.47

Genetic basis for clinical expression in multiple sclerosis. Brain (2002) 1.43

Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain (1996) 1.41

Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping. Hum Mol Genet (2004) 1.29

A bias-ed assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev (2002) 1.24

A meta-analysis of whole genome linkage screens in multiple sclerosis. J Neuroimmunol (2003) 1.13

The epidemiology of multiple sclerosis. Mayo Clin Proc (1997) 1.12

Transmission-ratio distortion and allele sharing in affected sib pairs: a new linkage statistic with reduced bias, with application to chromosome 6q25.3. Am J Hum Genet (2004) 1.10

Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol (1991) 1.06

Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. J Neurol Neurosurg Psychiatry (1997) 1.05

A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun (2002) 1.01

HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet (1997) 0.98

Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am J Hum Genet (2001) 0.97

A second-generation genomic screen for multiple sclerosis. Am J Hum Genet (2004) 0.94

A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet (2001) 0.91

Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet (1997) 0.90

A genome screen for multiple sclerosis in Italian families. Genes Immun (2001) 0.89

A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun (2002) 0.88

A whole genome screen for linkage in Turkish multiple sclerosis. J Neuroimmunol (2003) 0.85

Updated results of the United Kingdom linkage-based genome screen in multiple sclerosis. J Neuroimmunol (2003) 0.83

Articles by these authors

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

A second generation human haplotype map of over 3.1 million SNPs. Nature (2007) 85.39

Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature (2007) 75.09

Finding the missing heritability of complex diseases. Nature (2009) 67.95

Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature (2007) 65.18

A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet (2011) 59.36

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet (2003) 53.59

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science (2007) 51.70

The structure of haplotype blocks in the human genome. Science (2002) 50.88

A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80

Integrative genomics viewer. Nat Biotechnol (2011) 42.83

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature (2009) 35.48

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Genome-wide association studies for common diseases and complex traits. Nat Rev Genet (2005) 33.96

Integrating common and rare genetic variation in diverse human populations. Nature (2010) 32.30

The landscape of somatic copy-number alteration across human cancers. Nature (2010) 31.88

Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals. Nature (2005) 31.60

Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29

Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet (2008) 30.20

Somatic mutations affect key pathways in lung adenocarcinoma. Nature (2008) 30.02

Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science (2009) 29.83

Sequencing and comparison of yeast species to identify genes and regulatory elements. Nature (2003) 29.16

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science (2006) 27.49

Transcriptional regulatory code of a eukaryotic genome. Nature (2004) 27.21

Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol (2009) 27.17

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science (2006) 25.99

Efficiency and power in genetic association studies. Nat Genet (2005) 25.56

Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature (2005) 23.04

High-quality draft assemblies of mammalian genomes from massively parallel sequence data. Proc Natl Acad Sci U S A (2010) 22.97

ARACHNE: a whole-genome shotgun assembler. Genome Res (2002) 22.72

Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00

A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36

Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A (2009) 20.66

ALLPATHS: de novo assembly of whole-genome shotgun microreads. Genome Res (2008) 20.61

International network of cancer genome projects. Nature (2010) 20.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71

Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet (2007) 19.08

Genomic maps and comparative analysis of histone modifications in human and mouse. Cell (2005) 18.96

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A (2007) 18.83

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81

Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nat Biotechnol (2010) 18.44

The mammalian epigenome. Cell (2007) 18.13

Complement factor H variant increases the risk of age-related macular degeneration. Science (2005) 17.95

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Initial genome sequencing and analysis of multiple myeloma. Nature (2011) 17.28

Genome-wide detection and characterization of positive selection in human populations. Nature (2007) 17.27

Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med (2007) 17.06

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet (2003) 16.51

Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48

Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47

Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28

Gene expression correlates of clinical prostate cancer behavior. Cancer Cell (2002) 16.27

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol (2013) 16.13

Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet (2008) 15.89

Common deletion polymorphisms in the human genome. Nat Genet (2006) 15.66

A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63

Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature (2002) 15.36

Genetic mapping in human disease. Science (2008) 15.12

Calibrating a coalescent simulation of human genome sequence variation. Genome Res (2005) 15.04

Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet (2006) 14.76

Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66

The genomic complexity of primary human prostate cancer. Nature (2011) 14.06

Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05